Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,542.30
+14.30 (0.94%)
Jul 3, 2026, 3:29 PM IST
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 832.62 billion as of July 2, 2026. Its market cap has increased by 131.33% in one year.
Market Cap
832.62B
Enterprise Value
857.98B
Revenue
68.13B
Ranking
n/a
PE Ratio
93.76
Stock Price
1,542.30
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 832.62B, an increase of 1,655.18%. That is a compound annual growth rate of 35.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 832.62B | 39.20% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.79T |
| Cipla | 1.18T |
| Zydus Lifesciences | 1.14T |
| Mankind Pharma | 1.04T |
| Aurobindo Pharma | 932.40B |
| Alkem Laboratories | 665.08B |
| Glenmark Pharmaceuticals | 623.95B |
| Ipca Laboratories | 451.31B |